Healthcare provider profile · identity verified

Diego Rivera, MDPA

General Practice · LUBBOCK, TX · NPI 1104984988

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	577	60
Atorvastatin Calcium	Atorvastatin Calcium	463	149
Tramadol Hcl	Tramadol Hcl	457	74
Lisinopril	Lisinopril	359	116
Amlodipine Besylate	Amlodipine Besylate	331	107
Levothyroxine Sodium	Levothyroxine Sodium	189	53
Gabapentin	Gabapentin	178	56
Metformin Hcl	Metformin Hcl	174	56
Allopurinol	Allopurinol	163	52
Pravastatin Sodium	Pravastatin Sodium	129	43
Metoprolol Succinate	Metoprolol Succinate	127	40
Alprazolam	Alprazolam	120	24
Glipizide	Glipizide	104	34
Chlorthalidone	Chlorthalidone	103	31
Clonazepam	Clonazepam	100	18
Metformin Hcl Er	Metformin Hcl	98	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	96	30
Valsartan	Valsartan	82	26
Meclizine Hcl	Meclizine Hcl	80	30
Zolpidem Tartrate	Zolpidem Tartrate	77	17
Irbesartan	Irbesartan	75	22
Triamcinolone Acetonide	Triamcinolone Acetonide	72	44
Omeprazole	Omeprazole	70	25
Cefuroxime	Cefuroxime Axetil	68	56
Finasteride	Finasteride	68	24
Pantoprazole Sodium	Pantoprazole Sodium	65	32
Lorazepam	Lorazepam	63	suppressed
Carisoprodol	Carisoprodol	60	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	57	21
Rosuvastatin Calcium	Rosuvastatin Calcium	55	19
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	54	28
Sertraline Hcl	Sertraline Hcl	51	19
Furosemide	Furosemide	50	27
Telmisartan	Telmisartan	46	15
Amoxicillin	Amoxicillin	44	35
Lovastatin	Lovastatin	42	14
Pioglitazone Hcl	Pioglitazone Hcl	42	14
Tizanidine Hcl	Tizanidine Hcl	41	12
Jardiance	Empagliflozin	39	15
Potassium Chloride	Potassium Chloride	38	18
Escitalopram Oxalate	Escitalopram Oxalate	37	15
Doxycycline Hyclate	Doxycycline Hyclate	36	30
Clopidogrel	Clopidogrel Bisulfate	35	11
Solifenacin Succinate	Solifenacin Succinate	33	16
Meloxicam	Meloxicam	32	14
Spironolactone	Spironolactone	32	11
Fluticasone Propionate	Fluticasone Propionate	31	23
Trazodone Hcl	Trazodone Hcl	29	suppressed
Folic Acid	Folic Acid	28	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	26	suppressed
Losartan Potassium	Losartan Potassium	26	suppressed
Baclofen	Baclofen	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Mupirocin	Mupirocin	23	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Terbinafine Hcl	Terbinafine Hcl	22	14
Diclofenac Sodium	Diclofenac Sodium	21	12
Famotidine	Famotidine	20	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	18	11
Donepezil Hcl	Donepezil Hcl	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Prednisone	Prednisone	18	15
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	16	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	16	suppressed
Ondansetron Odt	Ondansetron	16	13
Trulicity	Dulaglutide	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Risperidone	Risperidone	14	suppressed
Azithromycin	Azithromycin	13	12
Colchicine	Colchicine	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Simvastatin	Simvastatin	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error